NEMO1: An Open Label Exploratory Dose Finding and Pharmacokinetic Clinical Trial of Bumetanide for the Treatment of Neonatal Seizure Using Medication Off-patent

Trial Profile

NEMO1: An Open Label Exploratory Dose Finding and Pharmacokinetic Clinical Trial of Bumetanide for the Treatment of Neonatal Seizure Using Medication Off-patent

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 30 Sep 2017

At a glance

  • Drugs Bumetanide (Primary) ; Phenobarbital
  • Indications Neonatal seizures
  • Focus Adverse reactions
  • Acronyms NEMO-1
  • Most Recent Events

    • 01 May 2015 Status changed from completed to discontinued according to results published in the Lancet Neurology.
    • 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top